Related references
Note: Only part of the references are listed.Breast intraductal nanoformulations for treating ductal carcinoma in situ I: Exploring metal -ion complexation to slow ciclopirox release, enhance mammary persistence and efficacy
Firas Al-Zubaydi et al.
JOURNAL OF CONTROLLED RELEASE (2020)
Pharmacokinetics of ciclopirox prodrug, a novel agent for the treatment of bladder cancer, in animals and humans
Scott James Weir et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Preclinical Pharmacokinetics of Fosciclopirox, a Novel Treatment of Urothelial Cancers, in Rats and Dogs
Scott J. Weir et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2019)
Optimization of composition and obtainment parameters of biocompatible nanoemulsions intended for intraductal administration of piplartine (piperlongumine) and mammary tissue targeting
Vanessa F. M. Carvalho et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2019)
Application and design of esterase-responsive nanoparticles for cancer therapy
Haonan Dong et al.
DRUG DELIVERY (2019)
Multifunctional nanoemulsions for intraductal delivery as a new platform for local treatment of breast cancer
Amanda Migotto et al.
DRUG DELIVERY (2018)
The effect of size and polymer architecture of doxorubicin-poly(ethylene) glycol conjugate nanocarriers on breast duct retention, potency and toxicity
Zichao Gu et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2018)
Bench-to-bedside translation of ciclopirox prodrug for the treatment of non-muscle invasive and muscle-invasive bladder cancer
Scott J. Weir et al.
CANCER RESEARCH (2018)
Comparison of the Neuroprotective and Anti-Inflammatory Effects of the Anthocyanin Metabolites, Protocatechuic Acid and 4-Hydroxybenzoic Acid
Aimee N. Winter et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2017)
Anti-oxidative effects of 4-hydroxybenzyl alcohol in astrocytes confer protective effects in autocrine and paracrine manners
Lidan Luo et al.
PLOS ONE (2017)
Superior efficacy of the antifungal agent ciclopirox olamine over gemcitabine in pancreatic cancer models
Chrysovalantou Mihailidou et al.
Oncotarget (2017)
Intraductal cisplatin treatment in a BRCA-associated breast cancer mouse model attenuates tumor development but leads to systemic tumors in aged female mice
Jolien S. de Groot et al.
ONCOTARGET (2017)
Lipophilic Prodrugs of SN38: Synthesis and in Vitro Characterization toward Oral Chemotherapy
Vaskor Bala et al.
MOLECULAR PHARMACEUTICS (2016)
Ciclopirox olamine inhibits mTORC1 signaling by activation of AMPK
Hongyu Zhou et al.
BIOCHEMICAL PHARMACOLOGY (2016)
Antileukemia Effect of Ciclopirox Olamine Is Mediated by Downregulation of Intracellular Ferritin and Inhibition β-Catenin-c-Myc Signaling Pathway in Glucocorticoid Resistant T-ALL Cell Lines
Jianrong Wu et al.
PLOS ONE (2016)
Bioerodable PLGA-Based Microparticles for Producing Sustained-Release Drug Formulations and Strategies for Improving Drug Loading
Felicity Y. Han et al.
FRONTIERS IN PHARMACOLOGY (2016)
TPGS2k/PLGA Nanoparticles for Overcoming Multidrug Resistance by Interfering Mitochondria of Human Alveolar Adenocarcinoma Cells
Dong-Fang Wang et al.
ACS APPLIED MATERIALS & INTERFACES (2015)
Investigation of factors influencing the hydrolytic degradation of single PLGA microparticles
Hakan Keles et al.
POLYMER DEGRADATION AND STABILITY (2015)
Oral ciclopirox olamine displays biological activity in a phase I study in patients with advanced hematologic malignancies
Mark D. Minden et al.
AMERICAN JOURNAL OF HEMATOLOGY (2014)
Nanosuspension for enhancement of oral bioavailability of felodipine
Bhanu P. Sahu et al.
APPLIED NANOSCIENCE (2014)
A Feasibility Study of the Intraductal Administration of Chemotherapy
Susan M. Love et al.
CANCER PREVENTION RESEARCH (2013)
Evaluating Prodrug Strategies for Esterase-Triggered Release of Alcohols
Christian Perez et al.
CHEMMEDCHEM (2013)
Intraductal Therapy of Ductal Carcinoma In Situ: A Presurgery Study
M. Ellen Mahoney et al.
CLINICAL BREAST CANCER (2013)
Cytomegalovirus Protease Targeted Prodrug Development
Hairat Sabit et al.
MOLECULAR PHARMACEUTICS (2013)
Determination of Drug Release Kinetics from Nanoparticles: Overcoming Pitfalls of the Dynamic Dialysis Method
Sweta Modi et al.
MOLECULAR PHARMACEUTICS (2013)
4-Hydroxybenzyl alcohol: A novel inhibitor of tumor angiogenesis and growth
Matthias W. Laschke et al.
LIFE SCIENCES (2013)
Noninvasive Detection of Passively Targeted Poly(ethylene glycol) Nanocarriers in Tumors
Yashveer Singh et al.
MOLECULAR PHARMACEUTICS (2012)
Influence of Molecular Size on the Retention of Polymeric Nanocarrier Diagnostic Agents in Breast Ducts
Yashveer Singh et al.
PHARMACEUTICAL RESEARCH (2012)
Ductal Carcinoma In Situ of the Breast
Richard J. Lee et al.
INTERNATIONAL JOURNAL OF SURGICAL ONCOLOGY (2012)
Preclinical and Clinical Evaluation of Intraductally Administered Agents in Early Breast Cancer
Vered Stearns et al.
SCIENCE TRANSLATIONAL MEDICINE (2011)
The antitumor activity of the fungicide ciclopirox
Hongyu Zhou et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
Status of Intraductal Therapy for Ductal Carcinoma in Situ
Meghan Flanagan et al.
CURRENT BREAST CANCER REPORTS (2010)
Chelation of intracellular iron with the antifungal agent ciclopirox olamine induces cell death in leukemia and myeloma cells
Yanina Eberhard et al.
BLOOD (2009)
Intracellular esterase activity in living cells may distinguish between metastatic and tumor-free lymph nodes
Elena Afrimzon et al.
CLINICAL & EXPERIMENTAL METASTASIS (2008)
Ultrasound-assisted crystallization (sonocrystallization)
M. D. Luque de Castro et al.
ULTRASONICS SONOCHEMISTRY (2007)
Survivin expression in in situ and invasive breast cancer relates to COX-2 expression and DCIS recurrence
N Barnes et al.
BRITISH JOURNAL OF CANCER (2006)
Ductal access for prevention and therapy of mammary tumors.
S Murata et al.
CANCER RESEARCH (2006)
The natural history of low-grade ductal carcinoma in situ of the breast in women treated by biopsy only revealed over 30 years of long-term follow-up
ME Sanders et al.
CANCER (2005)
Effect of perductal paclitaxel exposure on the development of MNU-induced mammary carcinoma in female S-D rats
H Okugawa et al.
BREAST CANCER RESEARCH AND TREATMENT (2005)
Medical progress - Ductal carcinoma in situ of the breast
HJ Burstein et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Ductal carcinoma in situ, complexities and challenges
GD Leonard et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2004)
Serine protease mechanism and specificity
L Hedstrom
CHEMICAL REVIEWS (2002)
Ductal carcinoma in situ of the breast:: a new phenotype classification system and its relation to prognosis
F Wärnberg et al.
BREAST CANCER RESEARCH AND TREATMENT (2002)
Share Paper
